Ebrahim N, Eissa T, Hussein M, Arafat A, Amin N. Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment. apjcb [Internet]. 23Aug.2025 [cited 31Aug.2025];10(3):689-98. Available from: https://www.waocp.com/journal/index.php/apjcb/article/view/1942